| 000 | 01704 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517225259.0 | ||
| 264 | 0 | _c20190125 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1473-5687 | ||
| 024 | 7 |
_a10.1097/MEG.0000000000001197 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuilcher, Katharina | |
| 245 | 0 | 0 |
_aChange of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland. _h[electronic resource] |
| 260 |
_bEuropean journal of gastroenterology & hepatology _c10 2018 |
||
| 300 |
_a1159-1167 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aBiological Products _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Therapy _xtrends |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesalamine _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSwitzerland |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aFournier, Nicolas | |
| 700 | 1 | _aSchoepfer, Alain | |
| 700 | 1 | _aSchibli, Susanne | |
| 700 | 1 | _aSpalinger, Johannes | |
| 700 | 1 | _aBraegger, Christian | |
| 700 | 1 | _aNydegger, Andreas | |
| 773 | 0 |
_tEuropean journal of gastroenterology & hepatology _gvol. 30 _gno. 10 _gp. 1159-1167 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MEG.0000000000001197 _zAvailable from publisher's website |
| 999 |
_c28611279 _d28611279 |
||